基于优化的卷积神经网络和多标准决策的皮肤癌分类
Neven Saleh1,2, Mohammed A Hassan3, Ahmed M Salaheldin4
1Systems and Biomedical Engineering Department, Higher Institute of Engineering, EL Shorouk Academy, Cairo, Egypt. nesaleh@msa.edu.eg.
Scientific reports
|July 27, 2024
概括
这项研究开发了51种用于皮肤癌分类的人工智能模型,发现AlexNet卷积神经网络与灰狼优化实现了94.5%的准确性. 功能减少改善了分类,减少了培训时间.
科学领域:
- 皮肤病学和人工智能研究
- 计算病理学计算病理学
- 医学图像分析 医学图像分析
背景情况:
- 早期发现皮肤癌对于有效治疗至关重要.
- 许多人工智能模型用于皮肤癌检测,但最佳模型选择往往被忽视.
- 对各种模型进行基准测试对于在皮肤癌诊断中推进AI至关重要.
研究的目的:
- 开发和比较多种人工智能模型用于皮肤癌分类.
- 通过系统的基准测试过程确定皮肤癌分类的最佳模型.
- 评估特征减少技术对模型性能的影响.
主要方法:
- 使用了四个卷积神经网络 (CNN) 架构 (AlexNet,Inception V3,MobileNet V2,ResNet 50) 来进行特征提取.
- 使用灰狼优化器 (GWO) 算法实现了功能减少,并与原始功能进行了比较.
- 使用六个机器学习 (ML) 分类器将皮肤癌图像分为四个类别,从而产生51个不同的模型.
- 采用RAPS (根据周边相似性对替代品进行排名) 多标准决策方法进行模型选择.
- 在国际皮肤成像协作 (ISIC) 2017年数据集上训练和测试模型.
主要成果:
- 亚历克斯网CNN结合经典的GWO算法来减少特征,成为最优的模型.
- 这种最佳模型在ISIC 2017数据集上实现了94.5%的高分类准确度.
- 使用GWO的特征减少在减少培训时间和提高分类准确度方面证明了好处.
- 在51个已开发的模型中,RAPS方法在强有力的选择表现最佳的模型方面被证明是有效的.
结论:
- 这项研究为皮肤癌分类模型提供了全面的基准.
- 最佳模型,GWO的AlexNet,为准确和高效的皮肤癌检测提供了一个有前途的方法.
- 功能减少技术对于改善医疗图像分析中的AI模型性能至关重要.
- 在复杂的分类任务中,RAPS方法是选择最佳AI模型的宝贵工具.
相关概念视频
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336


